Red Blood Cell Distribution Width as a Marker of Contrast Induced Nephropathy in Patients With Coronary Intervention
Red Blood Cell Distribution Width as a Predictor Marker of Contrast Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
Sponsor: Assiut University
Listed as NCT03164681, this observational or N/A phase trial focuses on Contrast-induced Nephropathy and remains ongoing. Sponsored by Assiut University, it has been updated 11 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
▶ Show 6 earlier versions
-
Jun 2019 — Nov 2020 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Jun 2018 — Jun 2019 [monthly]
Not Yet Recruiting
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — May 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Assiut University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.